- Home
- CCII vs ANL Comparison
CCII vs ANL Comparison
Compare CCII & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Company Overview
Basic Information| Metric | CCII | ANL |
|---|---|---|
| Founded | 2024 | 2004 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 355.3M | 293.4M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | CCII | ANL |
|---|---|---|
| Price | $10.29 | $7.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 74.5K | ★ 205.2K |
| Earning Date | 01-01-0001 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.07 | $0.88 |
| 52 Week High | $10.47 | $12.09 |
Technical Indicators
Market Signals| Indicator | CCII | ANL |
|---|---|---|
| Relative Strength Index (RSI) | 57.29 | 45.10 |
| Support Level | $10.28 | $7.21 |
| Resistance Level | $10.30 | $9.98 |
| Average True Range (ATR) | 0.03 | 0.97 |
| MACD | 0.00 | -0.30 |
| Stochastic Oscillator | 87.50 | 20.85 |
Price Performance
Historical Comparison CCII
ANL
About CCII Cohen Circle Acquisition Corp. II Class A Ordinary Shares
Cohen Circle Acquisition Corp II is a blank check company.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.